The FDA has approved a polypill as an initial treatment for hypertension in adults for the first time. Here’s what to know: 1. Widaplik — manufactured by George Medicines — is a polypill that contains ...

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase ...

The following is a summary of “Calcitonin gene-related peptide in newly diagnosed idiopathic intracranial hypertension: a ...

Despite its importance, problems related to CSF often go unnoticed until something goes wrong.

The Business Research Company's Idiopathic Intracranial Hypertension Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2035 The Business Research Company's ...

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

Idiopathic intracranial hypertension is caused by a buildup ... Finally, your vision will begin to deteriorate if you don’t seek treatment in time. It’s important to see a doctor if you ...

Diagnosing this rare case of idiopathic intracranial hypertension in a young patient ... to ensure accurate diagnosis and tailored treatment, offering the best possible outcome for the patient." ...